24 July 2018
Jesper Fahlen
DETAILS
Perstorp recently reported that
they have made significant progress in
‘future-proofing’ its Capa™ caprolactone monomer plant
in Warrington, United Kingdom.
The monomer plant will be made more robust
to ensure an even more reliable supply
for customers around the world.
This investment will also facilitate future debottlenecking
to support market growth. Perstorp is building
in the capability for the plant to run with a higher capacity,
which allows for increased production volumes in the future.
In addition, Perstorp is now starting
to debottleneck its Capa™ derivatives production units
at Warrington, UK to further support customer demand.
Stephen Lewis,
Vice President Business Unit Caprolactones
“We continue to see strong confidence and demand
in the caprolactone market, and in particular
for our range of caprolactone derivatives marketed
under the names Capa™ Thermoplastics and Capa™ Polyols.
In order to provide high quality products and a partnership
that strengthens our customers’ businesses,
we strive to increase even further
the reliability of manufacturing and supply aimed at the market”,
“In particular, the strong growth is largely driven
by our customers’ recognition of
the unique properties and performance advantages
of our Capa™ product range.
Capa™ Thermoplastics are utilized in diverse application areas
such as
Adhesives and Sealants, Medical, Bioplastics and Footwear.
An increasing demand leads to a strong need
to invest in additional capacity, in order to ensure
we meet our customer’s future requirements
and growth plans in a timely manner”.
Stephen Lewis
WWW.CHEMWINFO.COM BY KHUN PHICHAI
